A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder

Summary

The purpose of the study is to assess how well each dose of lumateperone (Dose 1 and 2) works when given alone as compared to placebo in participants with major depressive disorder (MDD; a medical condition characterized by a persistent feeling of deep sadness, hopelessness, and a loss of interest in activities for a prolonged period of time and interfere with ability to function).

Timeline

Start

2026-10-20

Primary completion

2029-09-20

Completion

2029-09-20

Drugs

Indications